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Abstract Arsenic toxicity is a worldwide health concern as
several millions of people are exposed to this toxicant via
drinking water, and exposure affects almost every organ sys-
tem in the body including the brain. Recent studies have
shown that even low concentrations of arsenic impair
neurological function, particularly in children. This re-
view will focus on the current epidemiological evidence
of arsenic neurotoxicity in children and adults, with
emphasis on cognitive dysfunction, including learning
and memory deficits and mood disorders. We provide
a cohesive synthesis of the animal studies that have
focused on neural mechanisms of dysfunction after arsenic
exposure including altered epigenetics; hippocampal function;
glucocorticoid and hypothalamus-pituitary-adrenal axis
(HPA) pathway signaling; glutamatergic, cholinergic
and monoaminergic signaling; adult neurogenesis; and
increased Alzheimer’s-associated pathologies. Finally,
we briefly discuss new studies focusing on therapeutic
strategies to combat arsenic toxicity including the use of
selenium and zinc.
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Introduction
Arsenic is ranked first among toxicants posing a significant
potential threat to human health based on known or suspected
toxicity [1]. This naturally occurring metalloid is a known
poison, a co-carcinogen, and in lower concentrations has been
shown to increase susceptibility to cognitive dysfunction [2].
Currently, the permitted concentration of arsenic in water is
10 μg/L (10 ppb). Yet, an estimated 100 million people
worldwide are exposed to excessive amounts of arsenic via
drinking water (in the ppm range). Many of these individuals
obtain drinking water from unregulated sources (wells) or live
in regions where arsenic levels are high, as in Bangladesh. As
arsenic leaches from rock formations into water sources as the
water table recedes, exposure to high amounts of arsenic will
continue to persist as the demand for clean water increases.
This phenomenon particularly affects the Western region of
the United States, where it is estimated that certain areas
contain up to 3100 μg/L arsenic (31 ppm) in drinking water,
on par with levels reported in Taiwan and China [2].While the
World Health Organization (WHO) and the Environmental
Protection Agency (EPA) regulate water sources of arsenic,
lack of strict regulations on food, beverages, and air quality
can lead to increased arsenic exposure [3]. Ingestion of arsenic
activates metabolic pathways for excretion, resulting in a
number of metabolites, some of which are more potent and
toxic than the originally ingested inorganic form of arsenic
(iAs), including mono- and dimethylated arsenicals [4–8].
All forms of arsenic, including inorganic and methylated
arsenicals, accumulate in many parts of the brain, with the
highest accumulation in the pituitary [9]. Additionally, arsenic
is a well-established teratogen that crosses the placenta during
development, and in high concentrations, induces growth
delays and neural tube defects [10–12]. Epidemiological stud-
ies reviewed in this paper have investigated the neurological
and cognitive effects of arsenic on children and adults.
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Evidence presented suggests that chronic ingestion of arsenic
alters a number of intelligence measures and induces learning
deficits and mood disorders like depression. Information on
dose, concentration, extent, and method of exposure of arsenic
will be given for each study. We provide a detailed review of
the mechanisms involved in arsenic-induced toxicity in the
brain. These include altered glucocorticoid signaling, cholin-
ergic and monoaminergic signaling, adult neurogenesis and
other forms of synaptic plasticity, and behavioral deficits
including learning, memory, and locomotion. The last section
of this review discusses new studies on therapeutics used in
rodent models that may eventually be useful for remedying
arsenic-induced neurological deficits in human populations.
Epidemiological Studies
Children Exposed to Arsenic: Cognitive Assessments
Over the past two decades, various epidemiological reports
have shown that arsenic exposure may alter cognitive func-
tion, particularly learning and memory during childhood. A
recently published meta-analysis focused on the impact of
arsenic exposure on intelligence measured by IQ tests [13••].
Researchers concluded that arsenic exposure was associated
with a 0.4 decrease in IQ in exposed children [13••]. This
appears to be a minor decrease in IQ, but these changes could
have cumulative effects later on in life. For our purposes, we
will provide a synopsis of epidemiological studies focusing on
other neurobehavioral measures in children.
Several studies have shown a relationship between low
arsenic exposure (in the parts-per-billion range) and children’s
intellectual performance on a battery of cognitive tests that
cover a number of skills and processes. For example, a 2007
study found a significant association between urinary arsenic
concentrations greater than 50 μg/L and poor scores on tests
measuring visual-spatial reasoning, language and vocabulary,
memory, intelligence, and math skills in 6-8 year old (y.o.)
children fromMexico [14]. It should be noted that researchers
found a sex-specific effect of arsenic: males performed more
poorly on all assessments compared to females. However,
males had higher arsenic concentrations (mean 11.85 μg/L)
in their urine, which could account for these differences. In
another cohort of children in Mexico (6-7 y.o. with 55 μg/L
urinary arsenic), researchers reported poorer scores in arsenic-
exposed children on measures of language and vocabulary
and a modest association with hyperactive behavior using the
attention deficit hyperactive disorder (ADHD) index [15]. In
India, a cross sectional study on 351 children (5-15 y.o.)
exposed to an average of 147 μg/L arsenic in water through-
out development and childhood found an association between
arsenic exposure and poor performance in several measures
focusing on vocabulary, math skills, memory, and overall
cognition; however, confidence intervals and the age range
of participants in this study were broad [16].When accounting
for age range and other covariates (education, levels of arse-
nic, socioeconomic status), there was a dose-dependent rela-
tionship between arsenic levels in water and poor performance
scores on intelligence measures [17]: children exposed to
>50 μg/L arsenic had poorer intellectual performance than
those exposed to <5.5 μg/L arsenic [17]. While low exposures
to arsenic (< 2 μg/L) resulted in no measurable effects on IQ,
moderate exposures (142 μg/L and 190 μg/L) resulted in
decreases of 5 and 10 IQ points, respectively [18]. These
findings, along with other studies (Table 1) support the asso-
ciation between moderate arsenic exposure and deficits in
cognitive skills in children exposed during development.
As mentioned above, a common finding in these studies
seems to be the differential effect of arsenic among young
males and females; while this has not received much attention
[19], some research suggests that arsenic impedes growth and
development in young females more thanmales, which in turn
could impact cognitive function [20]. In studies where urinary
arsenic levels between males and females are comparable,
females aged 5-15 y.o. had a larger negative response to
arsenic [21]. Overall, in addition to poor cognitive assess-
ments, children exposed to arsenic in well water also have
poor development scores (i.e., height), which correlates with
lower intellectual function; this effect may be more pro-
nounced in females than males [22].
In Utero and Cumulative Exposure to Arsenic
Most epidemiological studies focusing on the effects of arsenic
exposure in children, with exposures occurring across several
years, have reported impaired cognition regardless of the con-
centration of arsenic. Conversely, studies evaluating the impact
of arsenic exposure only in utero fail to show consistent
cognitive deficits. Analysis of arsenic in cord blood one day
after birth (1.33 μg/L) and subsequent behavioral assessment
(Brazelton Scale) showed an inverse correlation between arse-
nic levels and neurodevelopment in newborns in Nepal [23].
Yet, an early-life longitudinal study of pre- and postnatal
arsenic exposure reported no significant correlations between
maternal or child arsenic levels and psychomotor and mental
development index assessments, behavior, or the maternal
report of language acquisition in 18 month old children [24].
Additionally, infants born to mothers with urinary arsenic
levels of 80 μg/L during pregnancy showed no cognitive
impairment when accounting for age, sex, and socioeconomic
status [25]. Measurable impaired cognition becomes evident
later in life: a Bangladesh study from the same group demon-
strated a correlation between the mother’s and child’s urinary
arsenic content (80 and 51 μg/L respectively) and verbal IQ
and full scale IQ but only in females at 5 years of age [26•].
Research focused on the adolescent time period of
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development provides more insight, suggesting that long-term
cumulative exposure is more harmful for cognitive function
including alterations in pattern memory, attention set shifting
[27], full scale IQ, verbal IQ, and functional memory [28]. The
levels of arsenic among these different cohorts of teens were
highly variable, ranging from 17.8 μg/L as assessed in hair
[28] to 132 and 185 μg/L arsenic in well water [27]; thus,
conclusions determined from comparing these studies are lim-
ited. Additionally, data from toxin assessment in hair has been
deemed somewhat insufficient to predict health outcomes as
information of toxin content varies according to gender, eth-
nicity, and pharmacokinetics [29]. However, all groups in these
studies had developmental exposure to arsenic. As with other
teratogens, the timing, dose, and duration of arsenic exposure
seem to determine the extent of neurological insults on chil-
dren, and these insults may occur during development to
produce cognitive dysfunction in adolescence or adulthood.
Chronic moderate exposure to arsenic, more so than high
acute exposure, may induce greater harm on intellectual func-
tion in children. Several investigations by Wasserman and
colleagues showed that the relationship between arsenic ex-
posure and cognition in children might be age dependent. In a
study of arsenic-exposed children aged 6 y.o., researchers
found a negative association between arsenic and performance
on the Wechsler Preschool and Primary Scale of Intelligence
(WPPSI-III) [30]; yet this association was not as substantive
as the inverse association observed in 10 y.o. children, who
had longer arsenic exposure [17]. Both cohorts of primary
school children showed reduced intellectual function and
performance, reduced processing speed, and lower full-scale
raw scores with arsenic exposures between 5-50 μg/L during
development. Yet, the chronic nature of the exposure com-
bined with the concentration of arsenic had the most adverse
effect on cognitive ability and neurological functioning in
children.
Factors Comorbid with Arsenic Exposure
One difficulty in drawing conclusions of the effect of arsenic
on cognitive ability is that exposure is commonly associated
Table 1 Impacts of arsenic on cognition in children and adults
Cognitive
assessment
Exposure Age Finding Reference
Intelligence (IQ) Low and High Children ↓verbal IQ
↓total IQ
Calderon et al. 2001 [42]
Medium Children ↓total IQ Rosado et al. 2007 [14]
Low and High Children (5-15 y.o.) ↓total IQ Von Ehrenstein et al. 2007 [16]
Low Children (9-10 y.o.) ↓total IQ Wasserman et al. 2004 [17]
Low Children (6 y.o. and 10 y.o.) ↓total IQ Wasserman et al. 2007 [30]
Low and Medium Children (5 y.o.) ↓total IQ (females)
↓verbal IQ (females)






Medium Children (6-7 y.o.) ↓capacity in figure design, vocabulary, letter
sequencing
Rosado et al. 2007 [14]
Medium Children (6-7 y.o.) ↓capacity in vocabulary Roy et al. 2011 [15]
Low and High Children (5-15 y.o.) ↓capacity in vocabulary, language Von Ehrenstein et al. 2007 [16]
Low Adults ↓capacity in executive function, mental acuity,
verbal skills
O’Bryant et al. 2011 [43••]
Visual
perception
Medium Children (6-7 y.o.) ↓capacity in visual search Rosado et al. 2007 [14]
Low and High Children (5-15 y.o.) ↓capacity in picture completion, object
assembly
Von Ehrenstein et al. 2007 [16]
Mental health Medium Children ↑risk for ADHD Roy et al. 2011 [15]
Low Adults ↑incidence of depression Zierold et al. 2004 [53]
Medium Adults ↑symptoms of anxiety Dang et al. 2008 [50], Dang
et al. 2009
Low→ High Adults ↓quality of life and mental health Syed et al. 2012 [47]
High Adults ↑symptoms of altered mental health Fujino et al. 2004 [51]
Low→ High Adults ↑insomnia ↓general health Guo et al. 2007 [49]
Low→ High Adults ↑risk of psychiatric disorder, depression,
anxiety
Sen et al. 2012 [52]
Exposure
Low: less than 50 μg/L (ppb) urinary arsenic or water arsenic
Medium: between 50 μg/L (ppb) and 100 μg/L (ppb) urinary or water arsenic
High: more than 100 μg/L (ppb) urinary arsenic or water arsenic
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with other factors that could affect the outcomes of these
studies (Table 2). These include exposures to a mixture of
metals, low socioeconomic status, and poor nutrition.
Metal Mixtures
The presence of arsenic in water or the environment does not
preclude the presence of other elements; in fact, it is probable
that a number of metals (Pb, Mn, Cd, Hg) are comorbid in
individuals with arsenic exposure in the studies provided here.
Reports on developmental exposures to heavy metal mixtures
suggest that combined exposure is associated with greater risk
for cognitive dysfunction, including behavior and impaired
neurological (CNS) development [31]. The incidence of men-
tal retardation is highly correlated with the presence of soil
metals in rural areas (As, Cu, Pb, Mn, Hg), and the probability
of intellectual disability in children increases as the concen-
tration of arsenic and lead in the soil increases [32, 33]. Yet,
determining the effect of one metal in isolation is quite diffi-
cult. In several studies, the concentration of lead in blood,
urine, or water (while low), still positively correlates with
arsenic levels [23]. Lead in particular is a known toxicant
imparting severe neurotoxic effects on the brain especially in
children. Of the studies described here, only a few discuss
comorbid exposures and provide information about other
metal concentrations. Poor scores on cognitive assessments
have been reported in children exposed to both arsenic (slight-
ly above and below the 10 μg/L EPA standard) and manga-
nese (500 μg/L) in well water, though the arsenic and manga-
nese interaction was not significant [34]. Arsenic, in particu-
lar, was associated with poor working memory and lower
verbal comprehension scores as previously reported in a
smaller prospective study ([34]), although a significant
manganese arsenic interaction was found in this study [28].
As such, further investigation on developmental
neurotoxicology of arsenic in combination with other sub-
stances is warranted. The possibility that observations in ep-
idemiological studies may be induced by comorbid factors in
addition to arsenic cannot be ignored.
Socioeconomic Status
Overall, arsenic exposure is correlated with lower socioeco-
nomic status (SES) [14], and SES correlates with lower mea-
sures on tests assessing infant development and cognition
[25]. The effects of poverty and parental stress due to low
SES are significant risk factors in neurodevelopment disorders
[35], and parsing out these effects from arsenic exposure is
quite difficult. Additionally, control cases used for epidemio-
logical work are typically from more affluent areas without
arsenic exposure. In China, cross-sectional analyses have
shown that children who live in rural areas have lower IQ
scores than children who live in urban areas [18, 21, 36].
Children residing in poor rural areas are more often exposed
to arsenic, which may exaggerate the inverse associations
found between arsenic in drinking water and IQ scores [37].
Low SES is often associated with less education, especially in
developing countries; one study reported that cognitive ability
in children exposed to arsenic increased as maternal education
increased from primary to secondary school [16]. However,
many epidemiological studies that controlled for education as
a covariate still reported significant neurodevelopmental def-
icits imparted after arsenic exposure [23].
Nutrition
Malnutrition can have a substantial negative impact on cog-
nitive development and performance even in the absence of
arsenic or metal exposure. Children lacking proper nutrition
during development, such as iron deficiency, have deficits in
neurological function, including cognition [38]. Arsenic ex-
posure is thought to increase the risk for anemia, which is a
potential risk factor in blunted growth and development [39].
Current research has been focused on the possible connection
between the lack of proper nutrients in diet during develop-
ment (methionine, cytosine, protein, folic acid, vitamin B-12,
choline, and betaine) and developmental delay [40, 41]. These
nutrients are important as they boost the body’s methyl donor
availability, which is critical in the metabolism of arsenic.
Increased consumption of methionine, cysteine, and protein
aids in the methylation of arsenic, thus enhancing excretion in
individuals exposed to arsenic [41]. The ability of the devel-
oping body to metabolize arsenic and to properly execute
epigenetic modifications could be impaired by the accumula-
tion of arsenic. As such, understanding the nutritional status of
Table 2 Factors comorbid with arsenic exposure
Exposure to arsenic impacts performance on a variety of cognitive
assessments in children; however, other factors could contribute to the
negative effects of arsenic.
Metal mixtures: Arsenic is not the only naturally occurring element that
leaches into water sources. Other metals including lead, mercury,
manganese, cadmium, and copper exist in significant quantities,
particularly in well water. Thus, arsenic may not be acting alone in
disrupting cognition in children; it may be the mixture of metals that is
reducing intelligence and other measures of neurological function.
Socioeconomic status: Unfortunately, millions of children live in poverty
all over the world; and low socioeconomic status correlates with reduced
cognitive function. Children living in poor areas typically do not have
access to clean water and are more likely to be exposed to high levels of
arsenic.
Nutrition: Along with lower SES and exposure to metals, children
exposed to arsenic typically have poor nutrition, likely due to an
impoverished situation. Additionally, metabolism of arsenic can interfere
with nutrient absorbance. It’s likely that arsenic exposure in combination
with these other factors accounts for the cognitive deficits observed in
exposed children.
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the children in these studies may be critical to interpreting the
effects of arsenic on cognition.
Summary of Epidemiologic Studies in Children
Overall, we can ascertain certain patterns from the epidemio-
logical literature on the association between arsenic exposure
and cognitive performance in children. A number of studies
have shown that arsenic induces cognitive deficits in children,
even at low concentrations. Arsenic water levels or urinary
arsenic levels correlate with poorer performance and scores on
intelligence measures, and verbal IQ seems to be the most
affected cognitive skill. These effects persist into adolescence,
such that cumulative arsenic intakemay be a greater risk factor
than acute intake in cognitive dysfunction. Higher concentra-
tions of arsenic exposure can alter growth and development in
children, leading to neurological deficits, and females seem to
be at greater risk than males, although few studies have
systematically evaluated sex differences. Potentially con-
founding factors in these studies include the comorbidity of
other metals with arsenic exposure, the correlation between
high arsenic exposure and poor socioeconomic status, and
poor nutrition in children exposed to arsenic [42]. Studies on
cohorts from around the world, including China, the United
States, Taiwan, Bangladesh, and Mexico, have all provided
significant research supporting the negative effects of arsenic
on childhood development and cognitive ability.
Adults Exposed to Arsenic: Cognitive Assessments
Most epidemiological research has focused on cognition in
children, and reports on the effect of arsenic exposure on adult
cognition are limited. However, a series of studies has recently
revealed a significant correlation between arsenic exposure
and altered adult cognition, particularly for symptoms associ-
ated with Alzheimer’s disease. The FRONTIER project is an
ongoing cohort study focused on a group of West Texas
residents in an area that contains arsenic levels close to the
EPA standard in groundwater (3-15 μg/L). Long-term and
continuing chronic exposure to low levels of arsenic via
drinking water significantly correlated with poorer scores in
tests examining language, visual and spatial skills, and exec-
utive function, all of which indicate cognitive dysfunction
[43••]. Poorer scores in global cognition, processing speed,
and immediate memory were also found; these particular
deficits have been associated with Alzheimer’s disease [43••,
44•]. Individuals exposed to 10.6 μg/L arsenic scored signif-
icantly worse on global cognitive assessment compared to
those exposed to 6.5 μg/L arsenic, suggesting that 10 μg/L
EPA standardmay not be sufficient to prevent arsenic-induced
cognitive deficits [44•].
There are several caveats to the FRONTIER studies. The
Mini-Mental State Exam (MMSE) used for cognitive
assessment has been criticized for its bias against less educat-
ed participants [45, 46]; indeed, FRONTIER participants in
the 10.6 μg/L group did have less education than controls
[44•]. Additionally, most of these assessments rely on verbal
responses, reading, and writing, while other tests require
proper auditory perception and visual acuity. The average
age of the 434 FRONTIER participants in these studies was
62 years old, thus if arsenic exposure affected sensory, per-
ception, or communication, participants may perform poorly
even if no cognitive impairment exists. Finally, the arsenic
concentrations in both of these FRONTIER studies were
determined using the ArcGIS program based on ground water
measurements made by the Texas Water Development Board;
direct measurement of arsenic was not performed. However,
despite these limitations, the findings presented here are im-
portant in supporting that cumulative, long-term exposure to
low levels of arsenic, levels considered safe by the EPA, can
impart cognitive deficits in adults.
Adults Exposed to Arsenic: Psychological Assessments
While the number of studies concerning cognitive and mental
disorders after toxic exposures has increased over the past ten
years, specific characterization concerning arsenic exposure
and psychological health requires more epidemiological in-
vestigation. Of the studies presented here, several point to a
strong correlation between arsenic toxicity and mental health
status. These data are reported from all over the world includ-
ing China, Bangladesh, India, and the United States. Altered
cognition is typically concurrent with disturbances in
mental health. As such, it is difficult to assess the
validity of studies primarily focused on psychological
health in arsenic-affected individuals, as the previous
data we have presented shows a strong correlation between
arsenic exposure and cognitive deficits. However, despite the
overlap between psychological and cognitive disorders, there
is substantial evidence to suggest that arsenic exposure in-
creases the risk of impaired cognition and enhanced suscepti-
bility for mood disorders.
Bangladesh
Bangladesh has one of the highest reported arsenic exposure
rates in the world, and yet, few studies have explored the
relationship between arsenic exposure and mental health. A
recent cross-sectional study, published in 2012, found that
patients with arsenic poisoning reported a lower quality of life
and scored lower on a validated mental health index compared
to individuals without arsenic exposure [47]. Arsenic poison-
ing has strong societal implications in Bangladesh, often
resulting in individuals with arsenic exposure ostracized from
the community [47]. This lack of social acceptance could
contribute to the lower quality of life and mental health scores
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in these individuals; however, other studies on the effects of
arsenic and mental health concur with those reported in this
study.
China
China accounts for approximately half of the world’s arsenic
production and consequently its pollution [48], and there are
many regions that contain naturally high amounts of arsenic in
soil deposits. Arsenic toxicity studies from China typically
focus on symptoms of neurotoxicity, including loss of hearing,
loss of taste, blurred vision, and tingling/numbness in the
limbs [49]. Altered mental health is comorbid with these
ailments, including a prevalence of insomnia [49], anxiety
and depression [50], and symptoms of distress [51].
Assessments of mental health were congruent with edu-
cation levels of the participants; however, as described
above, exposure to metal mixtures is common, and
participants exposed to metals in one study showed signif-
icantly greater urine and hair concentrations of arsenic, lead,
and cadmium than control participants [50]. Additionally,
water in these villages contained between 15-1860 μg/L arse-
nic, much higher than the Chinese DrinkingWater Standard of
50 μg/L.
India
In India, over 1.5 million people have been exposed to high
levels of arsenic with more than 200,000 cases of arsenicosis.
Cross-sectional analysis of over 1169 arsenicosis patients
between the ages of 18-65 y.o. revealed that 19 % of patients
developed some type of psychiatric disorder, compared to an
average 7 % prevalence of mental disorders in India [69]. Of
the 19 % of patients, most were categorized as having depres-
sion and/or anxiety; yet, the prevalence of depression in India
is only 3.7 %. The participants in this study were from seven
different villages, 90 % of which had arsenic levels
ranging from 25-900 μg/L. Most patients were males
with low SES and a 25 % rate of unemployment. As
noted in the studies from Bangladesh, it is difficult to
determine if these patients exhibit depression due to the
state of their overall health (arsenicosis) or if depression
is a manifestation of the arsenic toxicity. However, in
Indian society, arsenicosis patients are able to maintain their
traditions, kinship, and cast relations to cope with stress of the
disease [52]. Similar to observations of the general population,
anxiety and depression were the most common psychiatric
disorders in arsenicosis patients; however, lower SES, the
diseases associated with arsenic poisoning, body image, and
low self-esteem are predisposing factors of psychological
issues in this population.
United States
The United States has more stringent standards of arsenic
water quality than other countries (the EPA limit is
10 μg/L), yet this concentration may not be low enough as
suggested by the literature on cognitive dysfunction. A 2004
cross-sectional study covered a wide range of locations in
areas with low concentrations of arsenic and revealed a sig-
nificant association between low arsenic exposure (2-10μg/L)
and poor mental health, particularly depression. Individuals
with cumulative, long-term exposure to low concentrations of
arsenic (2-10 μg/L) for more than 20 years were significantly
more likely to exhibit depressive symptoms than those drink-
ing less than 2 μg/L arsenic [53]. Interestingly, participants
consuming more than 10 μg/L arsenic were also more likely
to have had cardiac bypass surgery, high blood pressure, and
circulatory issues than those drinking less than 2 μg/L arsenic
in water [53]. Unlike studies from India, Bangladesh, and
China where low levels of arsenic were not assessed, this
study suggested that low exposure, under EPA limits of
10 μg/L, is associated with higher rates of adverse mental
health. However, evaluating the validity of the conclusions
from this study is difficult because of the lack of the critical
methodological information, (e.g., participant health status,
and the type and analysis of the assessment tools), which are
all important in interpreting the findings.
Summary
There are several limitations to these studies, including some
with small sample sizes, all with variable levels of arsenic
toxicity, and arsenic-affected individuals typically living in
rural areas and having lower SES. Additionally, assessment
of dose-response relationships and mental health has not been
determined: it would be useful to have high and moderate
arsenic exposures compared in the same study. While it is
difficult to disentangle the contribution of arsenic and that of
general health in many of the studies conducted in countries
outside of the United States, the findings presented thus far
demonstrate a correlation between arsenic exposure, cognitive
dysfunction, and mental health. There is clearly substantial
evidence that arsenic exposure diminishes cognition and in-
creases mood disorders in human populations. Animal and
invertebrate studies have replicated many of these observa-
tions and aided in the search for the mechanisms for the
adverse health impacts of arsenic.
Mechanisms of Action
It is difficult to use the epidemiological literature to identify
mechanisms, as long-term exposures to arsenic are likely
compounded with exposures to pollution, poor diet, and low
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SES. Basic science research is poised to control for these con-
founding factors, including extent and timing of exposure. This
research has determined that arsenic imparts its toxicity on the
body via a number of mechanisms. These include the depletion
of methyl groups affecting epigenetic profiles, the uncoupling of
oxidative phosphorylation and increased reactive oxygen spe-
cies, the inhibition of thiol-containing enzymes and proteins
(including the depletion of glutathione), altered signal transduc-
tion and cell proliferation, and reduced DNA repair inducing
genotoxicity [1, 6]. As thesemechanisms have been discussed in
detail in other reviews, we covermechanisms particularly related
to the brain. These include hippocampal dysfunction; gluta-
matergic, glucocorticoid, cholinergic, and monoaminergic
signaling; pathways associated with Alzheimer’s disease;
and synaptic plasticity, particularly neurogenesis. To begin,
we briefly provide results from the few studies focusing on
neural epigenetic patterns altered after arsenic exposure.
Epigenetic Patterns
Arsenic accumulation and subsequent toxicity is likely medi-
ated through multiple mechanisms of action. Of particular
interest over the past few years is the impact of arsenic on
the epigenome. While there have been several studies deter-
mining the impact of arsenic on epigenetic regulation in
cancer cells, the liver, and other parts of the body, very few
have focused the brain. Exposure to 3 and 36 ppm arsenic
throughout gestation increased DNA methylation on two
genes involved in neural plasticity in rat cortex and hippo-
campus at one month of age [54•]. Hypomethylation of these
genes in both regions was observed after four months of
cumulative exposure to arsenic; these animals also displayed
deficits in fear memory as well, although the link between
hypomethylation andmemorywas correlational. Since arsenic
metabolism requires methyl groups derived from S-
adenosylmethionine (SAM) for excretion, it is plausible that
arsenic depletes SAM leading to alterations in DNA methyl-
ation. In vitro studies corroborate this assertion: 25 μM arse-
nic exposure for 24 hours depleted SAM concentrations,
increased global DNA hypomethylation, and repressed
Dnmt1 and Dnmt3a expression [55]. Epidemiological work
has shown that DNA methylation is affected by arsenic in
human populations as well, including umbilical cord blood,
but discussion of those studies is beyond the scope of this
review [56–59]. We can determine that exposure to arsenic
does induce epigenetic modifications to the DNA, which may
result in aberrant gene expression even in the brain; however
the link between DNA methylation on particular genes and
cognitive deficits has yet to be elucidated.
Other epidemiological studies have determined the impact
of arsenic ingestion on histone modifications. Arsenic com-
pounds have been shown to alter gene expression and post-
translational modifications (PTM) of histones in vivo;
interestingly, researchers found a differential effect of arsenic
on global histone modifications among males and females
[60]. In vitro assessment of low doses of arsenic on histone
modifications has also been performed; however, detailed
discussion of this research is beyond the scope of this review
[60–62]. Rodent studies with prenatal exposure to 100 μg/L
arsenic demonstrated reduced global acetylation on lysine 9 of
histone 3 (H3K9ac) in the cortex and hippocampus of post-
natal day (PND1) pups, which was correlated to altered learn-
ing in adulthood [63]. Exposure to 3 and 36 ppm arsenic
throughout development up to four months reduced
myelination (for which methylation is required) and
dimethylation of arginine residues on histones [64]. This
could result from the altered expression and function of epi-
genetic modifiers or transcription factors, as arsenic impacts
zinc-finger protein expression and function [65].
These studies demonstrate that arsenic impacts DNAmeth-
ylation and histone modifications and alters the enzymes
responsible for regulating these modifications. The effects of
arsenic on the epigenome are related to the dose and extent of
arsenic exposure as seen before, but also type of histone
methylation mark, gene, and sex. As such, in determining
mechanisms of arsenic toxicity it will be important to control
for these variables both in epidemiological and molecular
studies in the future. Additionally, cumulative low-level ex-
posure to arsenic likely occurs over generations. The literature
suggests that females are differentially more affected by arse-
nic than males. Since females are the key source of
transgenerational effects (3rd generation ova are exposed to
the in utero environment), arsenic could be impacting
transgenerational epigenetics, including the imprinting of
genes (from both males and females). This area of research
could provide an insight into the effects of arsenic on the brain
and body, yet there are no published reports on arsenic expo-
sure and transgenerational epigenetic mechanisms to date.
The Hippocampus
Studies on the mechanisms of arsenic-induced toxicity have
established that arsenic alters learning and memory in behavior-
al assays and impacts multiple neurobiological processes includ-
ing those of neurogenesis and cholinergic, glutamatergic, and
monoaminergic signaling pathways. Recent work using animal
models has revealed potent alterations in hippocampal function,
morphology, and signaling leading to altered cognitive behavior
after arsenic exposure. While the exposure paradigms and con-
centrations of arsenic have been highly varied, the overall
conclusions have been congruent between studies (see Table 3).
In particular, behavioral studies using hippocampal-
dependent tasks, including the Morris Water Maze and fear
conditioning, have corroborated epidemiological evidence of
reduced cognition observed in humans with arsenic exposure.
Table 3 details the behavioral paradigms and arsenic
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exposures used in these studies. Results from this body of
literature suggest that regardless of dose, timing, or extent of
exposure, arsenic induces hippocampal-dependent behavioral
deficits in rodent models, suggesting impaired spatial, work-
ing, long-term, and short-term memory [63, 66–68].
Interestingly, the effect extends to nonmammalian species as
arsenic exposure inDanio rerio (zebrafish) induces deficits in
long-term memory as well [69]. Several of these behavioral
deficits can be ameliorated with treatment; for example, sodi-
um butyrate, a histone deacetylase inhibitor, attenuated defi-
cits seen in the radial arm maze after two weeks of arsenic
exposure of 100 μg/L during adulthood [66]. More detail on
therapeutic interventions after arsenic exposure will be
discussed in later sections of this review. Overall, work with
animal models has demonstrated that arsenic induces deficits
in multiple learning paradigms, particularly those relying on
proper hippocampal function. Yet, identifying the hippo-
campus as a sensitive area for arsenic’s effects does not
necessarily identify a molecular target. Alterations in
multiple signaling pathways are localized to the hippo-
campal formation, but it should be noted that mossy fiber
terminals in the hippocampus contain substantial amounts of
zinc. Thus, the sensitivity of the hippocampus may be due to
the effect of arsenic on zinc either via displacement or substi-
tution. To date, no studies investigating this mechanism have
been published.
Table 3 The impact of arsenic on behavioral tasks in rodent studies
Type of cognition Task Exposure Finding Reference
Learning and memory Morris water maze (MWM) Adult, chronic, high ↓acquisition Luo et al. 2009 [71]
Adult, chronic, low ↓acquisition Sharma & Sharma, 2013 [66]
Fear/cued conditioning Adult, acute, low ↓recall Cronican et al. 2013 [63]
8-way radial arm maze Developmental, chronic,
low
↓acquisition Martinez-Finley et al. 2009 [67]
Y-maze; MWM Adult, chronic, high ↓acquisition Jing et al. 2012 [68]
Radial water maze Adult, acute, low ↓acquisition Cronican et al. 2013 [63]
Novel object exploration Developmental, chronic,
low
↓performance Martinez-Finley et al. 2009 [67]
Adult, acute, low ↓performance Cronican et al. 2013 [63]






↑response time to completion
no change in low group
Luo et al. 2013 [86]
Developmental,
low→ high
No change in either group Gandhi et al. 2012 [87]
Rotarod Adult, subchronic, high ↓coordination ↑ataxia Yadav et al. 2009 [85]
Spontaneous locomotor
activity
Adults, chronic, low→ high Dose-related
↑locomotion with low dose
↓locomotion with high dose
↑ locomotion females
Bardullas et al. 2009 [83]
Adults, chronic, low→ high no change in low group
↓ locomotion
Rodriguez et al. 2010 [84]
Total movement Adult, chronic, low→ high ↓ movement at high dose Bardullas et al. 2009 [83]
Adult, subchronic, high ↓ total movement Yadav et al. 2009 [85]
Adult, chronic, low→ high ↓ total movement Rodriguez et al. 2010 [84]
Grip strength Adult, subchronic, high ↓ strength Yadav et al. 2009 [85]
Exposure type:
Developmental: in utero to postnatal exposure (maternal consumption of arsenic)
Adult exposure: from weaning up to death
Exposure level:
High exposure: ppm (mg/L)
Medium exposure: above 100 ppb (μg/L)
Low exposure: below 50 ppb (μg/L)
Low→ high; multiple doses examined
Exposure paradigm:
Acute: less than two weeks
Subchronic: less than one month
Chronic: more than one month
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Glutamatergic Signaling
Arsenic impacts the synaptic activity of neurons localized to
the hippocampus. Slices obtained from young and adult rats
exposed to 100 μM arsenite in vitro had reduced amplitudes
of excitatory post synaptic potentials (EPSPs) in the Schaffer
collateral/CA1 synapses. Exposure inhibited long-term poten-
tiation (LTP), a form of synaptic plasticity, in hippocampal
slices from adult but not young rats; however, this effect was
reversible after 20 minutes of washout. Arsenic exposure did
not impair paired-pulse facilitation, indicative of presynaptic
activity, suggesting that acutely applied arsenic does not affect
presynaptic neurotransmitter release [70]. However, compo-
nents of NMDA receptors, specifically NR2A, were reduced
after three months of arsenic exposure (2.72, 13.6, 68 mg/L
arsenic) in mice. Additionally, these mice exhibited morpho-
logical changes in hippocampal neurons—reduced size with a
condensed nucleus and cytoplasm—along with capillary ede-
ma and irregular vascular endothelial cell morphology [71].
Similar morphological changes in hippocampal neurons were
observed after a 3-month exposure of 8.2 mg/kg/day arsenic;
both the striatum and hippocampus contained abnormally
myelinated nerve fibers, while the hippocampus contained
reduced mossy fiber terminals [68]. Brief, two week exposure
to 100 μM arsenic also altered expression levels of mRNA for
synapse related genes, including increased Grin1, Syn2, and
Stx6 expression, similar to results from our studies [63, 72].
In addition to altered synaptic activity and synapse-related
gene expression, arsenic has been shown to impart alterations
in central pathways involved in mediating learning and mem-
ory in the hippocampus. Using a three-month exposure model
(from weaning until four months), arsenic-exposed animals
had decreased NR2A expression, PSD-95, and p-CAMKIIα
in the hippocampus with concurrent increased SynGAP ex-
pression, a known negative regulator of the Ras-MAPK path-
way [73]. Reduced p-ERK1/2 in the hippocampus was also
observed in the arsenic-exposed animals. These findings cor-
roborate our own work demonstrating reduced ERK2 in the
hippocampus after perinatal exposure to arsenic [74]. Thus,
the Ras-MAPK/ERK pathway appears to be sensitive to arse-
nic damage; interestingly, zinc has been shown to alter this
pathway as well [75]. It is possible that arsenic is acting in a
similar fashion. Overall, altered Ras-MAPK/ERK signaling,
LTP, and synaptic regulation in the hippocampus could un-
derlie behavioral deficits suggesting arsenic-induced alter-
ations in long-term episodic memory, associative learning,
spatial learning, and working memory.
Glucocorticoid Signaling
In addition to altered hippocampal-dependent behaviors,
depressive-like symptoms have been observed in arsenic-
exposed mice. We have demonstrated increased immobility
in the forced swim task and increased latency for escape in the
learned helplessness task, along with increased plasma corti-
costerone levels [74]. Corticosterone (CORT), the rodent
equivalent of cortisol, is a stress hormone that plays a role in
mediating the effects of the hypothalamus-pituitary-adrenal
(HPA) axis in response to “stressful” events ranging from fear
to learning. In humans, significant alterations in the HPA axis
have been connected to depressive-like symptoms, and pa-
tients with depression typically report stress as a major factor
in the onset of their depression. Thus, decreased behavioral
ability and increased depressive-symptoms in arsenic-exposed
animals correlate with the epidemiological data on reduced
cognition in humans; as such, arsenic may be mediating not
only cognitive impairments but also mood disorders in
humans via the glucocorticoid signaling pathway.
CORT signaling is mediated through the corticosterone
receptors, specifically the mineralocorticoid (MR) and gluco-
corticoid (GR) receptors. When activated, MR and GR trans-
locate to the nucleus to allow for binding to response elements
(MRE or GRE) on genes for transcriptional activation or
repression. CORTsignaling, via its receptors in the hippocam-
pus, is responsible for imparting an inhibitory tone for the
HPA axis. Our work has demonstrated nuclear levels of GR
are much lower in adult mice perinatally exposed to arsenic
than levels observed in controls in hippocampal tissue [67].
Additionally, we have shown decreased GR binding to and
expression ofH-Ras and Raf-1, genes involved in modulating
the MAPK pathway with GRE binding sites [76]. In vitro
studies have demonstrated that various levels of arsenic im-
pact GR-mediated transcription in a bidirectional manner:
high arsenic levels (1-3 μM) induce an inhibitory effect, while
low levels (0.05–1 μM) seem to produce a stimulatory effect
[77]. Arsenic’s impact on GR is predicated on the DNA
binding domain (DBD) within the GR. Other steroid recep-
tors, including the MR and the progesterone receptor respond
to arsenic in a similar biphasic manner as the GR [78].
Interestingly, arsenic’s effects on transcriptional regulation of
the estrogen receptor seem to be only inhibitory [79]. A recent
study predicted that the GR pathway was a common mediator
of metal-induced birth defects: indeed, arsenic-induced defi-
cits, specifically neurodevelopmental toxicity, were prevented
by inhibition of GR signaling in a chick embryo model [80].
Oscillatory signaling of the HPA axis, in addition to proper
GR localization for MAPK activation, is paramount for proper
learning and memory. This signaling may be impaired in
arsenic-exposed animals: while they have elevated circulating
CORT, their ability to initiate a proper HPA response is
blunted after a stressor [81•]. Thus, the susceptibility of the
GR to arsenic may play an important role in hippocampal-
related deficits, including reduced learning and increased
depressive-like symptoms (observed in rodent models) and
may underlie mood and cognitive deficits seen in human
studies as well.
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Cholinergic Signaling
Motor learning, cholinergic signaling, and locomotion are all
affected by arsenic exposure in rodent models. Early studies
demonstrated impaired motor coordination and delayed spon-
taneous alteration in rats chronically consuming arsenic
(36 mg/L) for four months [82]. However the increased loco-
motion reported in this study has been challenged by more
recent work: while altered locomotion is a common behavior
seen in arsenic-exposed mice, whether this behavior is hypo-
or hyperlocomotion seems to be dependent on sex and the
arsenic exposure paradigm (see Table 3 for studies). Low
levels of arsenic exposure seem to induce hyperactivity in
male mice, while high levels induce hypoactivity [83, 84].
Conversely, female mice consuming any level of arsenic
display hyperlocomotion [83]. Subchronic exposures to arse-
nic increase locomotion but impair motor coordination in both
sexes [85], but reports on in utero exposure are conflicting,
with some suggesting impaired neural reflexes and others
reporting no changes in locomotor behavior [86, 87]. A sim-
ilar dose relationship between locomotion and arsenic level
occurs in the zebrafish model, where moderate arsenic levels
reduced locomotion (line crossing) and high levels increased
the distance travelled [88]. Details on these studies, including
dose, timing of exposure, and age of behavioral assessment
are provided in Table 3. While parsing out verifiable locomo-
tor actions from anxiety is difficult and likely to impact these
studies, we can ascertain that high concentrations of arsenic
induce hypolocomotion, moderate levels of arsenic induce
hyperlocomotion, and low concentrations may induce no
change in locomotion.
Altered motor coordination and locomotion could arise
from abberant cholinergic functioning. Several reports have
noted reduced acetylcholinesterase (AchE) activity and cho-
line acetyltransferase (ChAT) functioning after arsenic expo-
sure. Female rats exposed to 20 mg/kg arsenic for 28 days
displayed deficits in the transfer latency of the passive avoid-
ance response and decreased labeling of muscarinic choliner-
gic receptors in the hippocampus and frontal cortex [89].
These brain regions had reduced AchE activity and ChAT
labeling after arsenic exposure as well. Interestingly, treatment
with a bioactive component of the spice curcumin during
arsenic exposure attenuated these observed effects in female
rats [89]. Exposure to less arsenic (5 mg/kg body weight) also
inhibited AchE activity in the brain and was associated with
poorer performance in operant learning [90]; another study
demonstrated that AchE activity decreased with increasing
arsenic concentrations in male rats after five days of exposure
[91]. Our analyses have shown that mRNA of AchE is in-
creased in the adult dentate gyrus after developmental arsenic
expoure to 50μg/L arsenic, suggesting a compensatory mech-
anism for altered AchE activity [72]. These studies provide
support for arsenic in the etiology of Alzheimer’s disease, as
more reports confirm reduced AchE and ChAT along with
degeneration of cholinergic neurons in AD pathology [92].
Alzheimer’s Disease
Global cognitive impairments assessed after arsenic exposure
have been associated with Alzheimer’s disease (AD) in the
human population; for an in-depth assessment of the relation-
ship between arsenic and Alzheimer’s disease, see [93]. For
the purposes of this review, we will discuss arsenic exposure
in the context of experimental studies. In vitro research using a
cholinergic neuronal cell line has demonstrated that sodium
arsenite and dimethylarsinic acid (DMA) have different ef-
fects on APP protein levels, β-amyloid formation, and altered
activity of AchE and ChAT [94]. These findings corroborate
our own: we have found altered mRNA expression of genes
associated with AD, including Appb1 and ApoE, and Ache in
the dentate gyrus of adult male mice after developmental
exposure to 50 μg/L arsenic [72].
For hallmark pathologies associated with AD, cell culture
studies have demonstrated arsenic exposure increases β-
amyloid protein and induces hyper-phosphorylation of tau
protein, oxidative stress, inflammation, endothelial cell dys-
function, and angiogenesis [95]. Interestingly, zinc has also
been shown to induce tau phosphorylation through an ERK-
sensitive mechanism [96]; again, this effect may be due to a
cation sensitive system (to zinc or arsenic) involving the Ras-
MAPK/ERK pathway. In 2012, Piacentini and colleagues
provided further evidence supporting the role of arsenic in
the etiology of AD. The authors found a significant correlation
between a genetic polymorphism of the protein glutathione S-
transferase GSTO1-1 in a population of 120 AD patients
compared to 114 healthy controls (OR=3.70); this transferase
has been linked to both Alzheimer’s and Parkinson’s disease
and is involved in arsenic metabolism, even in invertebrate
systems [97–99].While arsenic does not participate directly in
REDOX reactions, it can induce oxidative stress via depletion
of glutathione and impair REDOX reactions by inhibiting
enzymes with sulfhydryl groups [100]; and oxidative damage
is strongly associated with AD. In rodent models, arsenic
exposure results in vascular endothelial dysfunction, impair-
ment of learning and memory, altered nitrogen levels, and
oxidative stress; all of which have been associated with symp-
toms of dementia [66]. Treatment with a histone deacetylase
inhibitor, sodium butyrate, attenuated these cognitive and
vascular deficits observed in arsenic-exposed animals [66].
Sodium butyrate has been used in the treatment of depression
and improves cognitive skills in the Alzheimer’s mouse model
(APP/PS1-21) [101]. Overall, we confidently state that arsenic
imparts cognitive deficits associatedwith AD in rodent studies
of exposure; however, very few epidemiological studies have
investigated this relationship to date.
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Monoaminergic Signaling
Arsenic affects many transporter systems including the mono-
amines, dopamine (DA), serotonin (5-HT), and norepineph-
rine (NE). We have demonstrated that very low doses of
arsenic (50 μg/L) during development increase 5-HT1A recep-
tors in the dorsal hippocampus in adult offspring [74].
Exposure to moderate levels of arsenic (1, 2, and 4 mg/L) in
water for 60 days reduced levels of NE, DA, and 5-HT in both
the cerebrum and cerebellum of 7-week old mice in a dose-
dependent manner. mRNA levels of monoamine synthetases
(including dopamine β-hydroxylase, tyrosine hydroxylase
(TH), and tryptophan hydroxylase) were also all reduced after
exposure to 4 mg/L arsenic [102]. Evidence from other studies
using low to moderate doses of arsenic suggest differential
effects on monoaminergic signaling based on sex, as observed
in locomotion tasks. Four months of chronic exposure
to 0.05, 0.5, 5.0, or 50 mg/L arsenic in drinking water
decreased levels of DA in the striatum and hypothala-
mus in females (who also exhibited increased locomo-
tion) but not in males [83]. TH and thioredoxin (Trx-1
A) levels were reduced in the striatum of males but not
females; curiously, the opposite effect was observed in
the nucleus accumbens where TH and Trx-1A were
reduced in females but not males [83]. Conversely, in
a different study on rats ingesting 50 mg/L arsenic in
water, DA content in the striatum was increased in
males, although no changes in DA, its metabolites, or
serotonin were found in the prefrontal cortex or the
nucleus accumbens [84]. This group also reported alter-
ations in mRNA of several antioxidant genes including
superoxide dismutase (SOD), Trx-1, and NE and DA
receptor genes in arsenic-exposed animals dependent on dose
and region of interest in the brain (nucleus accumbens, pre-
frontal cortex, or striatum). Upregulation of antioxidant fac-
tors (Trx-1 and SOD) indicate compensatory mechanisms to
overcome the oxidative byproduct effects of arsenic toxicity
on thiol containing enzymes related to arsenic metabolism
[84]. It is difficult to propose a mechanism of action for
opposite effects based on sex for different brain regions.
However, evidence from these studies, while conflicting, sug-
gest that arsenic may induce a complex dose-response rela-
tionship, which may not be linear, on locomotion and the
nigrostriatal dopaminergic system as seen in other studies.
High levels of arsenic exposure, which have been
reviewed elsewhere, produce more definitive deficits
on dopaminergic and serotonergic signaling in the cor-
pus striatum, hippocampus, and frontal cortex [85, 103].
Interestingly, treatment with curcumin in these studies
attenuates deficits in monoamines and increases nitric
oxide (NO) and TH expression, in both sexes. More
details on therapeutic strategies to combat arsenic tox-
icity will be provided later.
Neurogenesis
Deficits in hippocampal-related behavioral tasks and
increased depressive-like symptoms suggest that arsenic
exposure induces changes in hippocampal morphology.
Recent studies have demonstrated deficits in adult
neurogenesis in the dentate gyrus of the hippocampus
in both developmental and adult exposures to arsenic.
Treatment for four months with 4 μg/L arsenic in
drinking water reduced proliferation of neural progenitor
cells and the number of mature neurons [104•].
Developmental exposure of 50 μg/L arsenic (in utero
and postnatal) altered differentiation but not proliferation
of neural progenitor cells in the adult hippocampus at
PND63 [72]. In both studies, deficits in adult
neurogenesis were ameliorated either after cessation of
the use of arsenic in water [104•] or with experience in
an enriched environment [72]. In vitro studies using P19
pluripotent cells cultured with varying concentrations of
arsenic (7.5-75.0 μg/L) demonstrated that arsenic
inhibited the formation of muscle and neuronal cells
during P19 cell differentiation in a dose dependent
manner. Deficits in neuronal differentiation may have
resulted from reduced expression of transcription factors
including neurogenin 1, neurogenin 2, and NeuroD as
compared to control P19 cultures. Further, Nanog ex-
pression increased during cell differentiation, suggesting
that arsenic impacts differentiation but not proliferation
[105].
Altered hippocampal morphology in CA1, CA3, and the
dentate gyrus was also observed during postnatal develop-
ment after I.P. injection of 1, 1.5, and 2.0 mg/kg arsenic from
PND4-11 [106]. Two weeks of 100 μM exposure to arsenic
reduced GFAP staining in the hippocampus in another study,
indicative of less neural stem cells [63], while exposure to
arsenic induced deficits in cell proliferation and increased
apoptosis in the brains of zebrafish [107]. These studies sug-
gest many different types of exposures to arsenic, including
brief, chronic, adult, or developmental, can impact the mor-
phology of the hippocampus. The effect of arsenic on
neurogenesis may be mediated through a signaling mecha-
nism already discussed: altered glucocorticoid and HPA axis
function. Neurogenesis is a particularly sensitive process in
the brain, and as such, is prone to insults like stress activity.
Recent in vitro studies done in human hippocampal progenitor
cells have demonstrated biphasic responses of adult
neurogenesis to cortisol; of particular interest is that increased
cortisol levels inhibit proliferation and differentiation possibly
mediated by the GR [108]. However, the effect of the GR on
adult neurogenesis is complex, as proposed by work showing
antidepressants mediate an increase in adult hippocampal
neurogenesis by activating the GR [109] as well. Arsenic
has an impact on adult neurogenesis and hippocampal-
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dependent learning and memory and induces cognitive defi-
cits and depressive-like symptoms; altered HPA axis regula-
tion, and particularly GR signaling in the hippocampus could
underlie all of these alterations seen in arsenic-exposed
animals.
Summary
Arsenic can alter a multitude of systems in the brain. Of
particular interest is HPA axis dysregulation that may un-
derlie several behavioral deficits, particularly related to the
hippocampus including alterations in adult neurogensis
and Ras-MAPK/ERK signaling. Additionally, arsenic
seems to have an impact on cholinergic and monoaminer-
gic signaling, though the mechanisms are not well under-
stood at this point. Rodent studies have provided useful
corroboration of the epidemiological evidence suggesting
that a number of mechanisms could underlie cognitive
deficits and mood disorders observed in human popula-
tions. More research focused on the dynamics of epige-
netics, particularly on mechanisms of learning and memory
and mood, will be important for understanding the impact
of arsenic on the brain. While it is unlikely one common
unifying mechanism for arsenic’s effects will be identifed,
some clues on how naturally present cations, like zinc,
interact with the system, may provide insight.
Therapeutics
Some arsenic-induced deficits have been ameliorated with
therapeutics. For example, in rodent studies, deficits in adult
neurogenesis can be attenuated either by abolishment of ex-
posure to arsenic water [104•], experience in an enriched
environment [72], or chronic antidepressant treatment (our
unpublished observations). Reduced expression of mono-
amines after arsenic exposure can be reversed by treatment
with curcumin [85] or taurine [102]. Studies described here
have demonstrated that use of selenium, zinc, arsenic chela-
tors, and environmental enrichment can attenuate systemic
deficits due to arsenic exposure.
The use of selenium as an anti-carcinogen and
chemoprotective compound and its interaction with arsenic
has been extensively studied in the cancer field. Selenium
forms conjugates with arsenic using glutathione for excretion
[110]. A study on selenium concentrations in adults and
children reported an inverse correlation between blood con-
centrations of selenium and urinary concentrations of arsenic
[111]. In rodent studies, selenium concentrations in the cere-
brum and cerebellum are reduced after exposure to 1-4 mg/L
arsenic [112]. Treatment with selenium (Se) can attenuate
some arsenic-induced deficits such as the inhibition of AchE
in arsenic-exposed fish (Channa punctatu), particularly if Se
treatment precedes arsenic exposure [113]. Another naturally
occurring metal, zinc, is an important component of several
enzymes involved in development and CNS function.
Concurrent exposure to 40 mg/kg arsenic and 4 % w/v zinc
in drinking water during pregnancy induced no teratological
deficits or arsenic toxicity in male offspring, as seen in
arsenic-only exposure. No changes were observed in sensory
reflexes, glutathione, or motor behavior, suggesting that zinc
treatment attenuated arsenic-induced deficts in mice [114].
Zinc has also been shown to be protective against arsenic-
induced apoptosis in neurons in vitro [115]. The mechanism
by which zinc prevents arsenic-induced toxicity has not been
eluciated, but we hypothesize that the Ras-MAPK/ERK path-
way is involved.
In India, where efforts for intervention of arsenic-
induced toxicity are at the forefront of research, the use
of chelators has been suggested for attenuating the effects
of chronic arsenic exposure, including thiol chelators that
form insoluble complexes with arsenic [116]. One such
chelator is monoisoamyl meso-2-3-dimercaptosuccinic ac-
id (MiADMSA), a lipophilic analog of DMSA and a strong
thiol chelator. Five days of MiADMSA was provided for
treatment of male rats after 10 weeks of exposure to
2 mg/kg arsenic. Compared to control animals, arsenic-
exposed rats displayed decreased locomotor activity, fore
and hind limb strength, reduced exploration, and impaired
learning in the morris water maze. Additionally, reduced
levels of malondialdehyde and oxidative stress markers
including superoxide dismutase, glutathione peroxidase,
glutathione reductase, and glutathione transferase were
measured in the cerebellum, hippocampus, and most
notably, the frontal cortex. Treatment with MiADMSA
attenuated all of these effects but failed to restore
performance back to control levels [117].
Other notable interventions include high protein diet, anti-
depressants, curcumin, and exposure to enriched
envrionments. Casein and pea protein, both of which have
antioxidant proteins, protected against the effects of arse-
nic on reproductive measures in female rats [118], while
curcumin in the diet attenuated the effects of arsenic on
malonaldehyde, glutathione, and superoxide dismutase in
several key brain regions, including decreased TH expres-
sion in the striatum [85]. Our own studies of treatment with
fluoxetine (Prozac) or exposure to an enriched environ-
ment after developmental arsenic exposure suggests that
the insults arsenic imparts can be ameliorated [72].
Research on therapeutic approaches will become more
pronounced as the number of people exposed to arsenic
increases. However, efforts to implement safe water pro-
grams have been successful in reducing arsenic exposure
in some parts of the world [119]. Arsenic remediation
endeavors remain the most effective method for reducing
exposure to this insidious toxic metalloid.
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Conclusion
The most recent report provided by the Agency for Toxic
Substances and Disease Registry (ATSDR) has suggested that
toxic exposures to arsenic may result in memory loss and
emotional instability in humans. Epidemiological studies from
the past decade have provided a wealth of information
supporting a strong correlation between arsenic exposure
and neurological and cognitive dysfunction in children and
adults. These deficits seem to be dependent on concentration,
timing, and duration of exposure, with cumulative arsenic
inducing more severe insults. Developmental exposure to
arsenic may impart damage on critical processes involved in
programming in the brain. Research in rodent models has
provided sufficient evidence to suggest that arsenic toxicity
affects multiple systems and specific pathways involved in
several aspects of learning, memory, movement, decision
making, and mood. The next phases of research will delve
deeper into mechanisms of action including epigenetics and
specifically focus on therapeutics for the treatment of arsenic
toxicity on the brain. More information on health and
exposure during the intrauterine period could be helpful
in ascertaining the true impact of arsenic exposure on the
central nervous system. Additionally, more epidemiologi-
cal studies, particularly in the United States, would be
useful in determining if the current standard (10 μg/L) will
be sufficient enough to block arsenic-induced neurotoxic-
ity, and if not, what can be done, either legislatively or
pharmaceutically to alleviate arsenic-mediated cognitive
deficits.
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